American Economic Planning Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$710K Sell
20,908
-915
-4% -$33.3K 0.19% 45
2019
Q2
$897K Sell
21,823
-101
-0.5% -$4.01K 0.27% 42
2019
Q1
$883K Buy
21,924
+430
+2% +$17.2K 0.28% 38
2018
Q4
$890K Hold
21,494
0.29% 35
2018
Q3
$899K Buy
21,494
+3,474
+19% +$134K 0.32% 28
2018
Q2
$620K Sell
18,020
-4,431
-20% -$151K 0.23% 35
2018
Q1
$756K Sell
22,451
-4,033
-15% -$139K 0.28% 35
2017
Q4
$910K Buy
26,484
+3,426
+15% +$117K 0.34% 30
2017
Q3
$781K Buy
23,058
+142
+0.6% +$4.56K 0.29% 28
2017
Q2
$730K Buy
22,916
+692
+3% +$21.8K 0.29% 28
2017
Q1
$721K Sell
22,224
-926
-4% -$29.2K 0.29% 27
2016
Q4
$713K Buy
23,150
+114
+0.5% +$3.48K 0.31% 23
2016
Q3
$740K Buy
23,036
+83
+0.4% +$2.77K 0.3% 24
2016
Q2
$767K Sell
22,953
-1,461
-6% -$46.6K 0.31% 22
2016
Q1
$687K Buy
24,414
+14,994
+159% +$428K 0.28% 23
2015
Q4
$288K Sell
9,420
-157
-2% -$4.94K 0.11% 41
2015
Q3
$285K Buy
9,577
+2,977
+45% +$95.5K 0.13% 36
2015
Q2
$210K Sell
6,600
-454
-6% -$14.8K 0.09% 44
2015
Q1
$233K Buy
7,054
+138
+2% +$4.39K 0.09% 37
2014
Q4
$204K Buy
+6,916
New +$198K 0.08% 41
2014
Q3
Sell
-7,121
Closed -$201K 37
2014
Q2
$201K Buy
+7,121
New +$203K 0.07% 36

Other funds holding PFE

American Economic Planning Group's PFE Position: Q3 2019 in Review

American Economic Planning Group reduced its Pfizer (PFE) stake by 4.2% in Q3 2019, selling an estimated $33.3K and leaving 20,908 shares worth $710K. The position accounts for 0.19% of the portfolio, ranked #45.

American Economic Planning Group first reported a position in PFE in Q2 2014 and has held it in 21 quarters since. The position peaked at $910K in Q4 2017. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • American Economic Planning Group held 20,908 shares of Pfizer worth $710K as of Q3 2019.
  • American Economic Planning Group sold 915 Pfizer shares in Q3 2019, an estimated $33.3K.
  • Pfizer made up 0.19% of American Economic Planning Group's portfolio in Q3 2019, its #45 holding.
  • American Economic Planning Group first reported a position in Pfizer in Q2 2014 and has held it in 21 quarters since.
  • American Economic Planning Group's Pfizer position peaked at $910K in Q4 2017.
  • 2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on American Economic Planning Group's 13F filing for Q3 2019, filed 9 Oct 2019.